SEC Form 4 · accession 0001628280-26-041331
Pacira BioSciences, Inc. · PCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan Slonin
Officer — Chief Medical Officer
Period of report
Jun 3, 2026
Accepted (ET)
Jun 5, 2026 · 5:57 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001396814
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 3, 2026 | F | 4,728 | $22.32 | D | 218,912 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.